TABLE 2.
Selected p53-responsive genes not significantly affected by the K317R mutationa
Gene | Alias | Description | mRNA level in IR-treated wt cells/mRNA level in untreated wt cells
|
mRNA level in IR-treated p53K317R cells/mRNA level in IR-treated wt cells
|
||
---|---|---|---|---|---|---|
Ratio | P value | Ratio | P value | |||
Ccng1 | Cyclin G | Cyclin G | 4.68 | 2.0 × 10−4 | 1.11 | 0.15 |
Bax | Bcl2-associated X protein | 3.70 | 5.2 × 10−5 | 1.13 | 0.24 | |
Trp53inp1 | Teap | Trp53-inducible nuclear protein 1 | 2.78 | 1.2 × 10−5 | 1.09 | 0.36 |
Ppm1d | Wip1 | Protein phosphatase 1D, Mg dependent, delta | 2.08 | 8.3 × 10−4 | 1.08 | 0.54 |
Cdkn1a | p21 | Cyclin-dependent kinase inhibitor 1A | 1.91 | 2.8 × 10−2 | 1.11 | 0.30 |
Top2b | Topoisomerase (DNA) II beta | 1.46 | 2.3 × 10−3 | 0.98 | 0.84 | |
Btg1 | B-cell translocation gene 1, antiproliferative | 1.46 | 3.4 × 10−3 | 1.08 | 0.36 | |
Mtap4 | Microtubule-associated protein 4 | 1.38 | 6.4 × 10−4 | 0.93 | 0.28 | |
Tnfrsf10b | Killer | Tumor necrosis factor receptor superfamily member | 1.30 | 3.8 × 10−2 | 1.00 | 0.99 |
Mdm2 | Transformed mouse 3T3 cell double-minute 2 | 1.27 | 4.5 × 10−2 | 1.05 | 0.41 | |
Pcna | Proliferating cell nuclear antigen | 0.98 | 6.1 × 10−1 | 0.86 | 0.30 | |
Gadd45a | Growth arrest and DNA damage-inducible 45 alpha | 0.89 | 1.2 × 10−2 | 1.13 | 0.22 | |
Xpc | Xeroderma pigmentosum, complement, group C | 0.85 | 3.6 × 10−2 | 0.99 | 0.90 | |
Birc5 | Survivin | Baculoviral IAP repeat-containing 5 | 0.83 | 7.2 × 10−2 | 0.90 | 0.09 |
Plk1 | Polo-like kinase homolog (Drosophila) | 0.63 | 5.4 × 10−4 | 1.20 | 0.15 | |
Cdc25c | Cell division cycle 25 homolog C (S. cerevisiae) | 0.61 | 1.5 × 10−3 | 0.98 | 0.86 | |
Gsn | Gelsolin | 0.51 | 1.4 × 10−5 | 1.01 | 0.90 | |
Cdc2a | Cell division cycle 2 homolog A (Schizosaccharomyces pombe) | 0.51 | 4.8 × 10−4 | 0.89 | 0.11 | |
Ccnb2 | Cyclin B2 | Cyclin B2 | 0.49 | 5.0 × 10−4 | 1.09 | 0.21 |
Myc | Myelocytomatosis oncogene | 0.19 | 6.5 × 10−5 | 0.83 | 0.09 |
wt, wild-type.